Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Perspective Therapeutics, Inc. Director's Dealing 2007

Jun 6, 2007

33510_dirs_2007-06-06_4daa1718-83f1-4ed0-8c4e-d5b96ab3fb48.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IsoRay, Inc. (ISR)
CIK: 0000728387
Period of Report: 2007-06-01

Reporting Person: KAUFFMAN ROBERT R (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2007-06-01 Stock Options (right to buy) $4.14 A 50000 Acquired 2017-06-01 Common Stock (50000) Direct